EMA Expired: Translarna (ataluren) — PTC Therapeutics International Limited

View source ↗

Summary

EMA status indicates that Translarna (ataluren) has expired for Duchenne muscular dystrophy as of 28 October 2024. The marketing authorization holder is PTC The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• Translarna (ataluren)

Snippet

Status: Expired. Therapeutic area: Muscular Dystrophy, Duchenne. MAH: PTC Therapeutics International Limited. Decision date: 28/10/2024. Conditional approval